news banner 2107 2

News

Print

Scientists Call for Improved Health Service Delivery through Quality Research and Collaboration

on .

asm2015

For Malawi to register remarkable improvement in the health delivery service, there is need for closer collaboration  between local and international health research institutions to  ensure  that the research being done is of high quality a development which can influence policy formulation.


The remarks were made by the Associate Director for the Malawi Liverpool Wellcome Trust MLW Dr Wilson Mandala during the opening of the 2015 annual scientific meeting being held at Makokola Retreat in Mangochi.


The annual scientific meeting which Malawi is hosting for the fifth time brings together scientists from The Malawi Liverpool Welcome Trust Clinical Research Programme, College of Medicine and the Wellcome Trust Liverpool Glasgow Centre for Global Health Research in Liverpool and other international research institutions.

Print

MLW in a Study to Improve Pneumonia Vaccines

on .

pneumoniapicThe Nurse Cordinator for the study, Roseline Nyirenda briefing the media about the study

The Malawi-Liverpool-Wellcome-Trust Clinical Research Programme (MLW has embarked on a study called “Pneumococcal Carriage in Vulnerable Populations in Africa” (PCVPA) which aims at improving pneumonia vaccines for Malawi and in some parts of Africa.

 

The pneumonia vaccine, called PCV13, has been given to newborns in Malawi since November 2011. This vaccine prevents disease caused by a germ called the pneumococcus which is found in the nose of many healthy people without causing any problem but in a small number of people this germ can cause pneumonia and meningitis.

Print

MLW in a Study to Improve Pneumonia Vaccines (2)

on .

pneumoniapicThe Nurse Cordinator for the study, Roseline Nyirenda briefing the media about the study

The Malawi-Liverpool-Wellcome-Trust Clinical Research Programme (MLW has embarked on a study called “Pneumococcal Carriage in Vulnerable Populations in Africa” (PCVPA) which aims at improving pneumonia vaccines for Malawi and in some parts of Africa.

 

The pneumonia vaccine, called PCV13, has been given to newborns in Malawi since November 2011. This vaccine prevents disease caused by a germ called the pneumococcus which is found in the nose of many healthy people without causing any problem but in a small number of people this germ can cause pneumonia and meningitis.